CSIMarket


Entera Bio Ltd   (NASDAQ: ENTX)
Other Ticker:  
 

Entera Bio Ltd

ENTX's Fundamental analysis








Looking into Entera Bio Ltd growth rates, revenue grew in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.3 %

Entera Bio Ltd 's net income grew by 29.94 % in III. Quarter 2024 year on year, above company average,

More on ENTX's Growth


Entera Bio Ltd
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Entera Bio Ltd PEG ratio is at 0.2 Entera Bio Ltd realized cash reduction of $ -0.14 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
8.76
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2178.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.


More on ENTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,273
 Net Income/Employee (TTM) $ 285,212
 Receivable Turnover (TTM) 4
 Tangible Book Value (Per Share $) 0.17

Entera Bio Ltd
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Entera Bio Ltd PEG ratio is at 0.2 Entera Bio Ltd realized cash outflow of $ -0.14per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
8.76
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2178.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.

Entera Bio Ltd Price to Book Ratio is at 14.18 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

More on ENTX's Valuation

  Market Capitalization (Millions $) 91
  Shares Outstanding (Millions) 38
  Employees 33
  Revenues (TTM) (Millions $) 0
  Net Income (TTM) (Millions $) 9
  Cash Flow (TTM) (Millions $) -5
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,273
  Net Income/Employee(TTM) $ 285,212
  Receivable Turnover Ratio (TTM) 4
  Tangible Book Value (Per Share $) 0.17

  Market Capitalization (Millions $) 91
  Shares Outstanding (Millions) 38
  Employees 33
  Revenues (TTM) (Millions $) 0
  Net Income (TTM) (Millions $) 9
  Cash Flow (TTM) (Millions $) -5
  Capital Exp. (TTM) (Millions $) -


    ENTX's Profitability Comparisons
Entera Bio Ltd